CCL2 and prostate carcinoma: Previous studies indicated that GDF15 from prostate cancer cells (PCa) stimulates bone marrow mesenchymal stem cells to differentiate into osteoblasts and enhances CCL2 expression, which attracts the tumour to bone surfaces and contributes to PCa bone metastasis.73